Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2023-08-15 Board/Management Inform…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Change in Leadership at Little Green Pharma 4 pages 807.2KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 16 August 2023, detailing a leadership transition at Little Green Pharma. It announces the CEO stepping down and the COO being appointed as the new CEO, effective from the upcoming AGM on 29 August. It includes biographical information about the new CEO and remuneration updates. The document does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is primarily an announcement of changes in the company's senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 9000 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is MANG with high confidence.
2023-08-15 English
Desert Flame granted Polish Marketing Authorisation 3 pages 490.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 2 August 2023 regarding Little Green Pharma's medicinal cannabis product receiving Marketing Authorisation in Poland. It details the product, distribution partner, market potential, and company background. There are no financial statements, regulatory certifications, or detailed financial data. The content is a corporate update about a marketing authorization and market entry, typical of a capital or business update rather than a financial report or regulatory filing. It is not an earnings release, annual report, or management discussion. The document is longer than 5,000 characters and provides substantive business information, not just a brief notice or report publication announcement. Therefore, the best fitting category is Capital/Financing Update (CAP), as it relates to a significant business development impacting the company's market and product distribution strategy.
2023-08-01 English
Change in substantial holding 6 pages 3.7MB
Regulatory Filings
2023-07-31 English
Change in substantial holding 10 pages 773.0KB
Regulatory Filings
2023-07-31 English
Application for quotation of securities - LGP 6 pages 28.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. This is a formal announcement related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. There is no financial performance data, management discussion, or audit information. The document fits the category of announcements regarding new share issues or capital changes rather than a full financial report or other types of filings.
2023-07-31 English
Notification of cessation of securities - LGP 4 pages 23.8KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the cessation of certain securities (share rights) for LITTLE GREEN PHARMA LTD. It details the number of securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement of a change in the company's issued capital related to securities ceasing to exist or lapsing. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement regarding capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 3563 characters, which is consistent with an announcement rather than a full report.
2023-07-31 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.